Full-Time

Quality Assurance Lead

August Bioservices

August Bioservices

51-200 employees

US-based CDMO for end-to-end drug development

No salary listed

Nashville, TN, USA

In Person

Bachelor's

Category
Biology & Biotech (1)

Get referred to August Bioservices

See people who can refer or advise you

Requirements
  • Bachelor’s degree in science or other related discipline, or equivalent level of skill and experience
  • A minimum of 4 years of AQL inspection experience in the pharmaceutical industry with liquid and lyophilized products
  • Quality Engineer Certification preferred
  • Highly organized individual with strong attention to detail
  • Ability to management time and priorities effectively
Responsibilities
  • Implement, coordinate, administer, and continuously improve the Quality Assurance AQL Visual Inspection / On-The-Floor program:
  • Responsible for development and quality oversight of the visual inspection /quality on the floor program.
  • Partners with manufacturing and other internal groups to establish a philosophy for visual inspection and develops the visual inspection qualification for operators and QA AQL Specialists.
  • Builds and maintains qualification kits.
  • Collaborates with manufacturing to develop the program for classification of rejects and AQL levels.
  • Participates in equipment design and start-up of automated equipment and manual/semi-manual visual inspection start up.
  • Supports implementation / qualification of automated inspection procedures.
  • Reviews all SOPs, policies, work instructions, batch records, etc. regarding visual inspection, defects, rejects, and defect kits.
  • Develops QA documents for visual inspection AQL inspection.
  • Quality reviewer/approver for visual inspection deviations, change controls, CAPAs, etc.
  • Completes training and maintains required qualifications for visual inspections.
  • Responsible for performing QA line clearance for visual inspection and audits of the fill/finish area.
  • Analyzes and trends AQL defects, provides metrics, and presents KPIs.
  • Reviews and approves process generated data from manufacturing visual inspection.
  • Ensure regular presence in operational areas and support personnel on quality matters.
  • Real-time batch record reviews and in-process auditing.
  • Routine walk-throughs of production areas, laboratories, and warehouse to ensure inspection readiness of the facility. Routinely communicate findings and ensure issues are corrected in a timely manner.
  • Ensures processes are executed according to batch records and procedures. Ensures any potential compliance issues identified during batch record review are corrected and clarified.
  • Provides constructive feedback to individuals executing batch records and communicates best practices to share with different areas of manufacturing.
  • Collaborates with planning groups to prioritize critical lot disposition. Also ensures that the schedule is being monitored and operations has all the required releases to ensure no downtime.
  • Identifies process improvements of batch record review and product disposition processes.
  • Oversees labeling activities, verifies labeling issued to and returned from operations.
  • Immediately escalates issues to QA management, submits event notifications where appropriate.
  • Ability to assess and triage deviations that occur with the local process team. Write, review, and assess deviations, and participate in investigations. Support CAPAs, gap analysis, and product complaints.
  • Develops strategy on how to achieve the work that needs to be completed, works with manufacturing to determine schedule and support. Ensures appropriate coverage which may include some evenings.
  • Provide support during internal / external / regulatory inspections.
  • Adhere to company policies and applicable regulatory agencies requirements (ICH, FDA etc.) to ensure compliance.
  • Communicate clearly with cross-functional teams.
  • Train and qualify future QA AQL Specialists
  • Other duties as assigned

August Bioservices is a US-based CDMO offering end-to-end drug development and manufacturing from pre-clinical to commercial. It combines large-CDMO scale with a customer-focused hybrid model to serve startups and big pharma. It provides full development programs including research, development, testing, lab services, and sterile fill/finish under one integrated process, ensuring cGMP and FDA-quality standards. Its goal is to help clients bring safe, effective drugs to market efficiently through a seamless, integrated pathway.

Company Size

51-200

Company Stage

Series B

Total Funding

$88.6M

Headquarters

Nashville, Tennessee

Founded

2017

Get referred to August Bioservices

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Manufacturing Chemist reported April 2026 plans for lyophilization and fill-finish expansion.
  • August’s 2025 FDA inspection was VAI, with no warning letters on record.
  • March 2026 named Jenn Adams Healthcare Technology CEO of the Year, aiding sales credibility.

What critics are saying

  • August’s 2026 expansion depends on filling new suites before rivals lock customers.
  • Single-site Nashville concentration exposes revenue to one facility outage, inspection, or permitting problem.
  • If sterile-fill demand softens, Oak HC/FT’s capital buildout becomes existentially underutilized.

What makes August Bioservices unique

  • August Bioservices specializes in sterile injectables, not broad-spectrum CDMO services.
  • Its Nashville campus combines development, analytical testing, and fill-finish under one roof.
  • Jenn Adams built August around embedded client teams and end-to-end program ownership.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

Health Savings Account/Flexible Spending Account

Unlimited Paid Time Off

Flexible Work Hours

Remote Work Options

Paid Vacation

Paid Sick Leave

Paid Holidays

Sabbatical Leave

Hybrid Work Options

Stock Options

Company Equity

401(k) Retirement Plan

401(k) Company Match

Performance Bonus

Profit Sharing

Employee Stock Purchase Plan

Relocation Assistance

Employee Referral Bonus

Student Loan Assistance

Parental Leave

Family Planning Benefits

Fertility Treatment Support

Adoption Assistance

Childcare Support

Elder Care Support

Pet Insurance

Bereavement Leave

Professional Development Budget

Conference Attendance Budget

Training Programs

Tuition Reimbursement

Professional Certification Support

Mentorship Program

Wellness Program

Mental Health Support

Gym Membership

Commuter Benefits

Meal Benefits

Phone/Internet Stipend

Home Office Stipend

Legal Services

Employee Discounts

Company Social Events

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

0%

2 year growth

-2%
The Healthcare Technology Report
Mar 18th, 2026
Jenn Adams named Healthcare Technology CEO of the Year.

Jenn Adams named Healthcare Technology CEO of the Year. Published. March 18, 2026 At this year's NYC Awards Night, The Healthcare Technology Repo had the privilege of recognizing several exceptional leaders advancing innovation across healthcare technology. Congratulations to Jenn Adams, CEO of August Bioservices, on being named Healthcare Technology CEO of the Year. Jenn has led August Bioservices since its founding in 2020, building a contract development and manufacturing organization (CDMO) dedicated to sterile injectable therapies. Headquartered in Nashville, the company provides development and manufacturing services that help drug developers advance innovative therapies from early development through commercialization. Accepting the award, Jenn shared: "When we started our company five and a half years ago, we had a really clear goal and we set out to build a CDMO focused on sterile injectables that could truly serve as a partner to our clients, providing deep technical expertise and a state-of-the-art facility and equipment - all designed to help advance innovative therapies through development and commercialization. Our aspiration is to show up so fully for our clients that they cannot tell the difference anymore. It's indistinguishable to them who is on their team and who is on our team because we're working shoulder to shoulder to make sure the drug is advanced. And then we're bridging the innovation and bringing it to patients who need that innovation in the form of therapies." Please join The Healthcare Technology Repo in congratulating Jenn Adams on this well-deserved recognition. Picture: Jenn Adams speaks at NYC Awards Night

Teknovation.biz
Dec 13th, 2024
Tennessee Emerges As A Leading State For Bioscience R&D

A new report from the Biotechnology Innovation Organization (BIO) and TEConomy Partners LLC finds Tennessee has emerged as a leading state for bioscience research and development, with bioscience RD accounting... The post Tennessee emerges as a leading state for bioscience RD appeared first on Teknovation.biz.

Teknovation.biz
Jun 30th, 2024
News & Notes | Ut Research Foundation Welcomes Four Interns

Like this story? Please share!News & Notes | UT Research Foundation welcomes four interns ETSU's Innovation Lab Director Dr. Audrey Depelteau served as a judge at last week's 2024 SelectUSA Investment Summit.From Knoxville:To promote the commercialization of University of Tennessee (UT) innovations and to help train the next generation of commercialization professionals, the UT Research Foundation (UTRF) recently welcomed three new interns and one returning intern across its Knoxville and Memphis offices.In Knoxville, Andrea Gutierrez-Cortez and Lauren Williams , rising second-year law students at UT, Knoxville (UTK), joined the team as Commercialization Analysts. Jacob Hale is returning for his second year with UTRF as a Senior Commercialization Analyst. Hale is a rising third-year law student, while Gutierrez-Cortez completed her bachelor’s degree in human biology at the University of California, San Diego, and Williams majored in biomedical engineering at UTK.and , rising second-year law students at UT, Knoxville (UTK), joined the team as Commercialization Analysts. is returning for his second year with UTRF as a Senior Commercialization Analyst. Hale is a rising third-year law student, while Gutierrez-Cortez completed her bachelor’s degree in human biology at the University of California, San Diego, and Williams majored in biomedical engineering at UTK

Teknovation.biz
Oct 22nd, 2023
News & Notes | Expansion Bucks For August Bioservices

Like this story? Please share!. .

Teknovation.biz
Jan 23rd, 2023
Launch Tennessee Provides Ssbci Update, Q4 Tn Deal Flow

Like this story? Please share!. .